The Future of Brain Cholesterol Turnover for Neurologic Diseases: A Podcast Program

Learn valuable information about the emerging role of brain cholesterol turnover in neurologic diseases and treatment options targeting this mechanism of action.

Share

Program Content

Activities

Treating Epilepsy With Cholesterol 24-Hydroxylase Inhibition
The Role of Brain Cholesterol Inhibition in the Treatment of Epilepsy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 15, 2023

Activities

Brain Cholesterol in Neurological Disease Management
Identifying the Emerging Role of Brain Cholesterol Turnover in Neurological Diseases Like Epilepsy
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2023

Expires: October 31, 2024

Emerging Therapies Impacting Brain Cholesterol
Assess the Efficacy and Safety of Emerging Strategies That Impact Brain Cholesterol Turnover
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2023

Expires: November 02, 2024

Faculty

cover img faculity

Cecil Hahn, MD, MPH, FRCPC

Professor
Pediatric Epileptologist
University of Toronto
Toronto, Ontario, Canada

cover img faculity

Jonathan J. Halford, MD

Professor
Director, Translational Research Unit
Department of Neurology
Medical University of South Carolina
Charleston, South Carolina

cover img faculity

H. Steve White, PhD

Professor, Department of Pharmacy
Co-Director, Center for Epilepsy Drug Discovery
School of Pharmacy
University of Washington
Seattle, Washington

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.